CLINICAL_TRIALS
trial_result
· 2016-09-19
Clinical Trial Update: An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia [Phase 4]
Summary
A Phase 4, double-blind evaluation of bupropion and citalopram was conducted in a single patient with Friedreich ataxia, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Friedreich Ataxia | Phase 4 | Status: COMPLETED | Results posted: 2016-09-19